Davis ID - Search Results

1

A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation.

Ellis RJ, Del Vecchio SJ, Gallagher KMJ, Aliano DN, Barber N, Bolton DM, Chew ETS, Coombes JS, Coory MD, Davis ID, Donaldson JF, Francis RS, Giles GG, Gobe GC, Hawley CM, Johnson DW, Laird A, Leung S, Malki M, Marco DJT, McNeill AS, Neale RE, Ng KL, Phipps S, Stewart GD, White VM, Wood ST, Jordan SJ. Ellis RJ, et al. Among authors: davis id. J Am Soc Nephrol. 2020 May;31(5):1107-1117. doi: 10.1681/ASN.2019121328. Epub 2020 Apr 1. J Am Soc Nephrol. 2020. PMID: 32238473 Free PMC article.

2

Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.

Ramdave S, Thomas GW, Berlangieri SU, Bolton DM, Davis I, Danguy HT, Macgregor D, Scott AM. Ramdave S, et al. J Urol. 2001 Sep;166(3):825-30. J Urol. 2001. PMID: 11490227

3

18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.

Johns Putra L, Lawrentschuk N, Ballok Z, Hannah A, Poon A, Tauro A, Davis ID, Hicks RJ, Bolton DM, Scott AM. Johns Putra L, et al. Among authors: davis id. Urology. 2004 Dec;64(6):1202-7. doi: 10.1016/j.urology.2004.07.024. Urology. 2004. PMID: 15596197

4

Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.

Lawrentschuk N, Poon AM, Foo SS, Putra LG, Murone C, Davis ID, Bolton DM, Scott AM. Lawrentschuk N, et al. Among authors: davis id. BJU Int. 2005 Sep;96(4):540-6. doi: 10.1111/j.1464-410X.2005.05681.x. BJU Int. 2005. PMID: 16104907

5

Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.

Lawrentschuk N, Davis ID, Bolton DM, Scott AM. Lawrentschuk N, et al. Among authors: davis id. BJU Int. 2006 May;97(5):916-22. doi: 10.1111/j.1464-410X.2006.06125.x. BJU Int. 2006. PMID: 16643471 Review. No abstract available.

6

Positron emission tomography and molecular imaging of the prostate: an update.

Lawrentschuk N, Davis ID, Bolton DM, Scott AM. Lawrentschuk N, et al. Among authors: davis id. BJU Int. 2006 May;97(5):923-31. doi: 10.1111/j.1464-410X.2006.06040.x. BJU Int. 2006. PMID: 16643472 Review. No abstract available.

7

Xenografting tumour beneath the renal capsule using modern surgical equipment.

Lawrentschuk N, Rigopoulos A, Lee FT, Davis ID, Scott AM, Bolton DM. Lawrentschuk N, et al. Among authors: davis id. Eur Surg Res. 2006;38(3):340-6. doi: 10.1159/000094093. Epub 2006 Jun 21. Eur Surg Res. 2006. PMID: 16791005

8

Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.

Lawrentschuk N, Davis ID, Bolton DM, Scott AM. Lawrentschuk N, et al. Among authors: davis id. Int J Urol. 2007 Feb;14(2):89-95. doi: 10.1111/j.1442-2042.2006.01659.x. Int J Urol. 2007. PMID: 17302562 Review.

9

Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.

Lawrentschuk N, Lee FT, Jones G, Rigopoulos A, Mountain A, O'Keefe G, Papenfuss AT, Bolton DM, Davis ID, Scott AM. Lawrentschuk N, et al. Among authors: davis id. Urol Oncol. 2011 Jul-Aug;29(4):411-20. doi: 10.1016/j.urolonc.2009.03.028. Epub 2009 Jun 12. Urol Oncol. 2011. PMID: 19523858

10

Cancer stem cells in urologic cancers.

Gedye C, Davidson AJ, Elmes MR, Cebon J, Bolton D, Davis ID. Gedye C, et al. Among authors: davis id. Urol Oncol. 2010 Nov-Dec;28(6):585-90. doi: 10.1016/j.urolonc.2009.06.010. Epub 2009 Nov 7. Urol Oncol. 2010. PMID: 19897386 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page